Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about GSK plc

Recent news which mentions GSK plc

Vaccine maker stocks fall on reports Trump plans to tap RFK Jr. to lead HHS
Tags Pharmaceuticals Health & Science Pfizer Inc
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags stocks Abbvie Inc Pultegroup Inc
From CNBC.com News
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
Tags Business News Respiratory syncytial virus Sanofi SA
From CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
Tags Astellas Pharma Inc Health care industry Healthy Returns
From CNBC.com News
Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future
Tags Pfizer Inc US: News Pharmaceuticals
From CNBC.com News
Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market
Tags Pharmaceuticals Health & Science Pfizer Inc
From CNBC.com News
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
Tags Personnel Vaccinations Biotechnology
From CNBC.com News
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
Tags Pfizer Inc US: News Merck & Co Inc
From CNBC.com News
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
Tags Pfizer Inc US: News Health & Science
From CNBC.com News
Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits
Tags Breaking News: Markets Sanofi SA Markets
From CNBC.com News
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
Tags Breaking news Companies Moderna Inc
From CNBC.com News
Moderna says FDA delayed RSV vaccine approval to end of May
Tags Pharmaceuticals Health & Science US: News
From CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
Tags Politics Amphastar Pharmaceuticals Inc AstraZeneca PLC
From CNBC.com News
Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use
Tags Health & Science Pharmaceuticals US: News
From CNBC.com News
Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients
Tags AstraZeneca PLC Health care industry Healthy Returns
From CNBC.com News
Pfizer RSV vaccine maintains protection in older adults over two seasons in trial
Tags Pfizer Inc US: News Pharmaceuticals
From CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
Tags Novartis AG Investment strategy GSK plc
From CNBC.com News
Cramer's Lightning Round: 'Hold off' on Kroger
Tags Market Outlook Stock Picks Markets
From CNBC.com News
GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost
Tags Pharmaceuticals Health & Science Pfizer Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags GSK plc Microsoft Corp Business
From CNBC.com News
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
Tags Biotech and Pharmaceuticals Biotechnology Business News
From CNBC.com News
RSV vaccine from GSK shows potential to protect adults 50 to 59
Tags US: News Social issues Pfizer Inc
From CNBC.com News
Moderna combination Covid, flu vaccine moves to final stage trial after positive data
Tags BioNTech SE US: News Pfizer Inc
From CNBC.com News
Covid, RSV and flu vaccines are now available — here's how to decide whether to get them together
Tags Health care industry Business COVID/19
From CNBC.com News
Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
Tags Biotech and Pharmaceuticals Biotechnology Immunizations
From CNBC.com News
Covid vaccine rollout begins early in the UK with new variant under watch
Tags Pfizer Inc Europe Economy Coronavirus
From CNBC.com News
These 10 medications are likely targets for Medicare price negotiations this fall
Tags Business GSK plc Health care industry
From CNBC.com News
GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine
Tags Biotech and Pharmaceuticals Biotechnology Vaccinations
From CNBC.com News
GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales
Tags US: News Pharmaceuticals Health & Science
From CNBC.com News
CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older
Tags Business GSK plc Health care industry
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.